GB1334705A - Pharmaceutical compositions containing kynurenic acid derivatives - Google Patents

Pharmaceutical compositions containing kynurenic acid derivatives

Info

Publication number
GB1334705A
GB1334705A GB1334705DA GB1334705A GB 1334705 A GB1334705 A GB 1334705A GB 1334705D A GB1334705D A GB 1334705DA GB 1334705 A GB1334705 A GB 1334705A
Authority
GB
United Kingdom
Prior art keywords
ester
pharmaceutical compositions
compositions containing
acid derivatives
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of GB1334705A publication Critical patent/GB1334705A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1334705 Derivatives of 4-oxo-1,4-dihydroquinoline-2-carboxylic acid IMPERIAL CHEMICAL INDUSTRIES Ltd 19 May 1971 [19 June 1970] 29905/70 Heading C2C [Also in Division A5] The invention comprises (with numerous exceptions) compounds of formula wherein R<SP>1</SP> is H, Me or Et, R<SP>2</SP> is OH or C 1-6 alkoxy, and ring A may be substituted by 1 or 2 of C 1-5 alkyl and alkoxy, benzyl, benzyloxy, acetyl, halogen, CF 3 , NO 2 or NH 2 , or it may be fused with a 5,6- or 7,8-benzene ring, a methoxysubstituted benzene ring, or with (CH 2 ) 4 ; and their non-toxic pharmaceutically acceptable salts. In examples, the acids are prepared by hydrolysing the esters, which are in turn made by reacting a correspondingly substituted aniline with an ester of oxaloacetic or acetylenedicarboxylic acid, and heating the ester of 1-phenylaminoethylene-1,2-dicarboxylic acid so formed; exceptionally, an ester of the above formula containing an NH 2 substitute is prepared by reducing the corresponding nitrocompound.
GB1334705D 1970-06-19 1970-06-19 Pharmaceutical compositions containing kynurenic acid derivatives Expired GB1334705A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2990570 1970-06-19

Publications (1)

Publication Number Publication Date
GB1334705A true GB1334705A (en) 1973-10-24

Family

ID=10299112

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1334705D Expired GB1334705A (en) 1970-06-19 1970-06-19 Pharmaceutical compositions containing kynurenic acid derivatives

Country Status (3)

Country Link
DE (1) DE2130408A1 (en)
FR (1) FR2100798B1 (en)
GB (1) GB1334705A (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4128649A (en) 1977-06-29 1978-12-05 Sandoz, Inc. 4-Hydroxy-pyrido[2,3-b]pyridine-2(1H)-one-3-carboxylic acids and esters
US4273930A (en) * 1977-06-20 1981-06-16 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acid esters
US4281131A (en) 1977-06-20 1981-07-28 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
EP0062001A2 (en) * 1981-03-24 1982-10-06 Ciba-Geigy Ag Acyl quinolinone derivatives, processes for their preparation, pharmaceutical compositions containing them and their use
EP0303387A1 (en) * 1987-08-12 1989-02-15 Merck Sharp & Dohme Ltd. Kynurenic acid derivatives useful in the treatment of neurodegenerative disorders
EP0339485A1 (en) * 1988-04-26 1989-11-02 The Du Pont Merck Pharmaceutical Company 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
US4963566A (en) * 1986-03-28 1990-10-16 Otsuka Pharmaceutical Co., Ltd. Benzimidazolyl-sulfinyl-tetrahydroquinolines
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US5270309A (en) * 1987-08-12 1993-12-14 Merck Sharp & Dohme Limited Kynurenic acid derivatives useful in the treatment of neurodegenerative disorders
US6861424B2 (en) 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
US7056923B2 (en) 2002-12-11 2006-06-06 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
EP1851739A2 (en) * 2004-12-29 2007-11-07 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositoins and methods related thereto
WO2010128345A1 (en) * 2009-05-05 2010-11-11 Szegedi Tudományegyetem Kynurenic acid analogues, pharmaceutical compositions containing same and use of said compounds for the treatment of headache

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865831A (en) * 1972-06-09 1975-02-11 Upjohn Co 1,1{40 ,4,4{40 -tetrahydro-4,4{40 -dioxo(6,6{40 biquinoline)-2,2{40 -dicarboxylates
FR2827599A1 (en) * 2001-07-20 2003-01-24 Neuro3D Treating central nervous system disorders, e.g. anxiety, depression, schizophrenia or pain, using new or known 2-substituted quinoline or quinoxaline derivatives having xanthenuric acid modulating action

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1207771A (en) * 1968-03-18 1970-10-07 Warner Lambert Pharmaceutical Anti-virally active quinoline derivatives

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273930A (en) * 1977-06-20 1981-06-16 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acid esters
US4281131A (en) 1977-06-20 1981-07-28 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
US4128649A (en) 1977-06-29 1978-12-05 Sandoz, Inc. 4-Hydroxy-pyrido[2,3-b]pyridine-2(1H)-one-3-carboxylic acids and esters
EP0062001A2 (en) * 1981-03-24 1982-10-06 Ciba-Geigy Ag Acyl quinolinone derivatives, processes for their preparation, pharmaceutical compositions containing them and their use
US4476132A (en) * 1981-03-24 1984-10-09 Ciba-Geigy Corporation Acylquinolinone derivatives, and antiallergic preparations and methods of inhibiting allergic reactions using them
EP0062001B1 (en) * 1981-03-24 1987-05-27 Ciba-Geigy Ag Acyl quinolinone derivatives, processes for their preparation, pharmaceutical compositions containing them and their use
US4963566A (en) * 1986-03-28 1990-10-16 Otsuka Pharmaceutical Co., Ltd. Benzimidazolyl-sulfinyl-tetrahydroquinolines
US5270309A (en) * 1987-08-12 1993-12-14 Merck Sharp & Dohme Limited Kynurenic acid derivatives useful in the treatment of neurodegenerative disorders
EP0303387A1 (en) * 1987-08-12 1989-02-15 Merck Sharp & Dohme Ltd. Kynurenic acid derivatives useful in the treatment of neurodegenerative disorders
EP0339485A1 (en) * 1988-04-26 1989-11-02 The Du Pont Merck Pharmaceutical Company 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US7176207B2 (en) 2001-06-06 2007-02-13 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
US6861424B2 (en) 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
US6995156B2 (en) 2001-06-06 2006-02-07 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
US7026323B2 (en) 2001-06-06 2006-04-11 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
US7056923B2 (en) 2002-12-11 2006-06-06 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
US7084142B2 (en) 2002-12-11 2006-08-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
EP1851739A2 (en) * 2004-12-29 2007-11-07 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositoins and methods related thereto
EP1851739A4 (en) * 2004-12-29 2012-08-29 Naturon Inc Xanthurenic acid derivative pharmaceutical compositoins and methods related thereto
US8361734B2 (en) 2004-12-29 2013-01-29 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
US8697674B2 (en) 2004-12-29 2014-04-15 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
US10370335B2 (en) 2004-12-29 2019-08-06 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
WO2010128345A1 (en) * 2009-05-05 2010-11-11 Szegedi Tudományegyetem Kynurenic acid analogues, pharmaceutical compositions containing same and use of said compounds for the treatment of headache

Also Published As

Publication number Publication date
FR2100798B1 (en) 1975-10-10
DE2130408A1 (en) 1971-12-23
FR2100798A1 (en) 1972-03-24

Similar Documents

Publication Publication Date Title
GB1334705A (en) Pharmaceutical compositions containing kynurenic acid derivatives
ES484578A1 (en) Substituted quinoline carboxylic acid derivatives
GB1397008A (en) Derivatives ofypsilon-glutamyl-4-nitroanilide
ES412859A1 (en) Process for preparing 7-(alpha-hydroxy-alpha-phenyl)acetamido-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid and derivatives thereof
GB1159493A (en) Metal Chelates
ES391496A1 (en) Fused ring indole derivatives and a process for the manufacture thereof
ES293930A1 (en) Preparation of 6-aminoacylpenicillanic acids
GB1049710A (en) Phenylalanine derivatives and a process for the manufacture thereof
GB1505020A (en) Substituted 2-phenylimino-thiazolines a process for their preparation and their use as ectoparasiticides
GB1240817A (en) Herbicidal agents
GB1316361A (en) 5h-dibenzazepines
GB1377959A (en) Amino acids
GB1360939A (en) Silver dye bleach process
GB1479969A (en) Fluorinated carboxylic acids and processes for their preparation
ES424204A1 (en) 1-oxadethiapenicillanic acid derivatives
GB1479608A (en) Amino acids and the preparation thereof
GB1197692A (en) Thienylcarboxamides and their preparation
GB1063364A (en) Oxazine compounds and the preparation thereof
GB1331181A (en) Phenylacetohydroxamic acids process for their manufacture and preparations containing them
ES447615A1 (en) Derivatives of 7-aminocephalosporanic acid
GB1152885A (en) Indazole-3-yl-Oxyalkanoic Acids and process for the preparation thereof
GB985966A (en) Thiazine derivatives
JPS55151555A (en) Proline derivatives and their production
ES445336A1 (en) Oxoindanylpropionic acids and process for the preparation thereof
GB1418888A (en) Phenolic amino acids

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees